← Back to signals
ABT
BUYAbbott Laboratories
Health Care
0.88
PEGY ratio
Rank #143
Why This Matters
This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 69.8% annually over 5 years. Pays a 2.9% dividend yield.
ABT trades at 24.6x earnings against 25.0% capped growth (actual 69.8%) + 2.9% yield (PEGY 0.88). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 69.8%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-06-02
Valuation
24.6x
P/E Ratio
Growth
69.8%
5yr EPS
Income
2.9%
Div Yield
PEGY Components
PEGY Score0.88
Denominator27.9%
EPS (TTM)$3.57
Market Data
Price$87.78
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.88→0.88(+0.00)
Rank
#141→#143(2 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only